Center for Reproductive Rights Submits Scathing Critique of Proposed Fertility Benefits Rule, Demanding Comprehensive Coverage

The Center for Reproductive Rights (CRR) has formally submitted a comprehensive comment to the Departments of Health and Human Services (HHS), Labor, and Treasury, vehemently opposing the recently proposed "Excepted Fertility Benefits" rule. The CRR’s submission, dated July 13, 2026, meticulously outlines what it describes as significant deficiencies in the proposed framework, arguing that it falls far short of ensuring equitable access to essential fertility treatments, particularly In Vitro Fertilization (IVF). Instead of mandating broad insurance coverage, the proposed rule, according to the CRR, would establish an optional, supplemental insurance model with a potentially restricted scope, effectively allowing employers to sidestep comprehensive care obligations. The organization is calling for the immediate withdrawal of this proposed rule, advocating instead for the inclusion of all-encompassing fertility care, including IVF, within the Affordable Care Act (ACA) marketplace plans and all public health insurance programs, such as Medicaid and Medicare.

Background: A Shifting Landscape for Fertility Care

The proposed "Excepted Fertility Benefits" rule emerges at a critical juncture in the ongoing national conversation surrounding reproductive healthcare access. For years, individuals and couples facing infertility have grappled with the significant financial burdens and systemic barriers to accessing vital treatments like IVF. Infertility, defined by the Centers for Disease Control and Prevention (CDC) as the inability to conceive after one year of unprotected sex, affects an estimated 6.1 million people in the United States, representing about 10% of the reproductive-aged population. The emotional and financial toll of infertility is profound, and the cost of IVF cycles can range from $12,000 to $20,000 per cycle, with many individuals requiring multiple cycles.

Historically, insurance coverage for fertility treatments has been a patchwork, often left to the discretion of individual employers and states. While some states have enacted mandates requiring insurance plans to cover certain fertility services, these laws vary significantly in their scope and applicability. The federal government’s involvement, particularly through the ACA, has been a point of contention, with reproductive rights advocates pushing for broader inclusion of fertility services under its umbrella. The proposed rule, therefore, represents a federal attempt to define parameters for fertility benefits, but its current form is drawing sharp criticism for its perceived inadequacy.

The Center for Reproductive Rights’ Core Objections

The CRR’s comment letter, a detailed 20-page document, articulates a multi-faceted critique of the proposed rule. At the heart of their opposition lies the fundamental argument that the rule fails to establish a baseline of mandated coverage for IVF and other essential fertility treatments. The CRR asserts that by allowing employers to offer fertility benefits as a separate, supplemental insurance plan, the rule risks creating a two-tiered system where only those with the means or in particularly progressive workplaces will have access to comprehensive care.

"This proposed rule is a step backward, not forward," stated a representative from the Center for Reproductive Rights in a hypothetical press release accompanying their comment submission. "It offers a flimsy opt-out rather than a robust mandate. Millions of Americans struggling with infertility deserve guaranteed access to treatments like IVF, not the promise of a limited, optional add-on that can be easily excluded or underwritten. We urge the Departments to reconsider this approach and instead champion a future where fertility care is treated as essential healthcare, fully integrated into all insurance plans."

The CRR’s comment highlights several specific concerns:

• Lack of Mandate for IVF: The most significant criticism is the absence of a requirement for insurance plans to cover IVF. The CRR views IVF as a medically necessary treatment for many individuals experiencing infertility and argues that its exclusion from a baseline coverage requirement is discriminatory and detrimental to reproductive health outcomes.
• Supplemental Plan Framework: The proposed reliance on supplemental insurance plans is seen as a major flaw. The CRR argues that this model can lead to limited coverage options, higher out-of-pocket costs for individuals, and a lack of parity with other essential health benefits. Employers might opt for plans with restrictive eligibility criteria, limited treatment options, or capped annual benefits, leaving many individuals unable to afford the full course of treatment.
• Potential for Segregation and Discrimination: By allowing employers to segregate fertility benefits, the CRR fears this could inadvertently lead to further stratification and potential discrimination. Employees in companies that do not offer robust supplemental plans or choose not to participate in them would be left without coverage, exacerbating existing health disparities.
• Insufficient Scope of Coverage: The CRR anticipates that even within supplemental plans, the scope of covered services might be narrowly defined. This could exclude crucial elements of fertility treatment, such as diagnostic testing, multiple IVF cycles, or treatments for underlying medical conditions contributing to infertility.

A Call for Comprehensive and Equitable Coverage

The Center for Reproductive Rights’ proposed alternative is clear and resolute: the Departments should withdraw the proposed rule and, instead, implement regulations that mandate comprehensive fertility care coverage across the board. This includes:

• Mandatory Coverage for IVF and Other Medically Necessary Treatments: Ensuring that IVF and other evidence-based fertility treatments are covered as essential health benefits.
• Inclusion in ACA Marketplace Plans: Integrating comprehensive fertility coverage into all plans offered on the ACA marketplaces, providing a safety net for individuals who do not have employer-sponsored insurance.
• Coverage for Public Health Insurance Plans: Extending mandatory coverage to Medicaid and Medicare beneficiaries, recognizing that infertility affects individuals across all socioeconomic strata and age groups.
• Broad Definition of Fertility Care: Advocating for a definition of fertility care that encompasses a wide range of diagnostic services, medical treatments, and assistive reproductive technologies necessary to achieve pregnancy.

Chronology of the Proposed Rule and Public Comment Period

The journey of the "Excepted Fertility Benefits" proposed rule has been a subject of intense scrutiny and anticipation within the healthcare and reproductive rights communities.

• May 13, 2026: The Departments of Health and Human Services, Labor, and Treasury jointly publish the proposed rule in the Federal Register, initiating a public comment period. This announcement signals the federal government’s intention to provide guidance and define parameters for employer-sponsored fertility benefits.
• May 2026 – July 2026: Various advocacy groups, healthcare providers, and individuals begin to review the proposed rule and prepare their responses. Discussions and consultations among stakeholders intensify as they analyze the potential implications.
• July 13, 2026: The Center for Reproductive Rights submits its detailed comment letter, formally voicing its opposition and outlining its recommendations. This submission represents one of the most significant and comprehensive critiques to date.
• July 2026 onwards: The comment period for the proposed rule will continue, allowing other interested parties to submit their feedback. The federal agencies are expected to review all submitted comments before making a final decision on the rule.

Broader Implications and Potential Impact

The outcome of this regulatory process holds significant implications for millions of Americans. If the proposed rule is finalized without substantial amendments, it could:

• Exacerbate Health Disparities: Individuals without robust employer-sponsored insurance or those in states without their own fertility mandates would likely face continued barriers to accessing care. This could disproportionately affect lower-income individuals and marginalized communities.
• Stifle Innovation and Access: A fragmented and optional approach to fertility benefits might disincentivize employers from offering comprehensive coverage, potentially slowing the broader integration of fertility services into mainstream healthcare.
• Increase Out-of-Pocket Costs for Patients: The reliance on supplemental plans could translate to higher deductibles, co-pays, and co-insurance for individuals seeking fertility treatments, making it financially prohibitive for many.
• Perpetuate Stigma: Treating fertility as a niche or optional benefit could inadvertently reinforce the societal stigma surrounding infertility, which is often viewed as a personal failing rather than a medical condition.

Conversely, if the CRR’s call for comprehensive coverage is heeded, it would represent a significant advancement in reproductive healthcare equity. Mandated coverage would ensure that IVF and other fertility treatments are accessible to a much broader segment of the population, regardless of their employment status or geographic location. This would align with the growing recognition of fertility as a critical component of overall reproductive health and well-being.

The Road Ahead

The Center for Reproductive Rights’ strong stance against the proposed "Excepted Fertility Benefits" rule underscores the deep divisions and ongoing debates surrounding the provision of fertility care in the United States. As the federal agencies deliberate on the public comments, the pressure to enact a rule that prioritizes equitable access to comprehensive fertility treatments, including IVF, will undoubtedly intensify. The CRR’s detailed critique serves as a powerful reminder that for millions, fertility care is not a luxury, but a necessity, and its accessibility should be a fundamental right, not an optional benefit. The coming months will be critical in determining the future landscape of fertility coverage and its impact on the reproductive journeys of countless Americans.